Venous Recanalization. Controlled

Chronic Venous Occlusions

Chronic Venous Occlusions are often difficult to cross requiring 3-5 guidewires and take between two to six hours to recanalize. VeinWay is a medical device company developing a novel “one and done” device for recanalizing chronic venous occlusions.

About us

VeinWay is a medical device company changing the paradigm on chronic venous disease treatment by providing physicians with a dedicated purpose-built venous occlusion recanalization device. This tool is built to expand the physician’s ability to safely recanalize complicated and diffuse occlusions that were previously uncrossable, as well as shorten venous occlusion crossing time. VeinWay addresses a market of 1.7M Deep Vein Thrombosis (DVT) patients annually, half of which return with Post Thrombotic Syndrome (PTS) and 20% of those have fully occluded veins. The VeinWay catheter was developed as part of the MEDX Xelerator’s Entrepreneur-in-Residence program designed to promote internal innovation. VeinWay is a portfolio company of MEDX Xelerator, a medical device incubator formed as an initiative of MEDX Ventures Group together with Boston Scientific, Intellectual Ventures and Sheba Medical Center.

The Team

jordan_

Jordan Pollack

CEO

Jordan has led VeinWay since its establishment in November 2020. He has spent several years at Boston Scientific as an R&D, Quality, Process, and Manufacturing Engineer. He developed several balloon catheters including the Ranger Paclitaxel Coated Balloon. He worked on the manufacturing floor for nitinol self-expanding stents including the Epic, Innova, and Eluvia nitinol stent models. He did Design Assurance work for nitinol implants such as WATCHMAN™ and its delivery system where he worked extensively in a strong medical device quality system. While working as a process development engineer, Jordan worked on the extrusion floor, developed the Comet II FFR guidewire, and the Mamba IC micro catheter where he developed several processes for manufacturing these products. Jordan has extensive engineering experience and knowledge working in a rigorous quality system. Jordan has a BSE and MSE in Biomedical Engineering from the University of Michigan and an MBA in Healthcare Innovation from Reichman University.
ben_

Ben Friesem

CTO

Ben joined Veinway as co-founder to lead our R&D program. With almost 10 years’ experience in medical device research and development, Ben brings to this position a significant track record in medical device innovation. His experience ranges from developing implants for minimally invasive spinal orthopedics (Nuvasive), basic academic research, to intravascular implant development in the field of structural heart. In his previous role as Senior Development Engineer at Restore Medical, Ben played a major role designing and developing the Contraband System, a nitinol based cardiovascular implant and subsequent transcatheter delivery system to treat CHF. He has taken products from the concept generation stage to clinical trials. He is listed on 6 issued and pending patents. He is a broadly experienced engineer skilled in nitinol and catheter design and has extensive knowledge of the start-up ecosystem. Ben holds a B.Sc. in Biomedical Engineering from the California Polytechnic State University (Cal Poly), a M.Sc. in Biotechnology Engineering from Ben Gurion University, and an MBA in Healthcare Innovation from Reichman University.

News & Events

MEDX Xelerator, the leading medical device and digital medicine Incubator, in cooperation with the Innovation Authority of Israel,  has founded three new start-up companies.
MEDX Xelerator, the leading medical device and digital medicine Incubator, in cooperation with the Innovation Authority of Israel,  has founded three new start-up companies.
MEDX Xelerator, the leading medical device and digital medicine Incubator, in cooperation with the Innovation Authority of Israel,  has founded three new start-up companies.
MEDX Xelerator, the leading medical device and digital medicine Incubator, in cooperation with the Innovation Authority of Israel,  has founded three new start-up companies.
MEDX Xelerator, the leading medical device and digital medicine Incubator, in cooperation with the Innovation Authority of Israel,  has founded three new start-up companies.
MEDX Xelerator, the leading medical device and digital medicine Incubator, in cooperation with the Innovation Authority of Israel,  has founded three new start-up companies.

Partners

VeinWay is a member of MEDX Xelerator, a medical device incubator backed by:

Contact us

For more information please contact jordan.pollack@veinway.com